Nanobiotix (NASDAQ:NBTX) Shares Up 6.7% – Here’s Why

Nanobiotix S.A. (NASDAQ:NBTX)’s share price was up 6.7% during trading on Wednesday . The company traded as high as $3.47 and last traded at $3.29. Approximately 38,075 shares traded hands during mid-day trading, an increase of 71% from the average daily volume of 22,202 shares. The stock had previously closed at $3.08.

Analysts Set New Price Targets

Separately, UBS Group raised Nanobiotix to a “hold” rating in a research report on Monday, February 17th.

Nanobiotix Stock Up 6.7 %

The stock’s fifty day moving average price is $3.42 and its 200-day moving average price is $4.00.

Institutional Investors Weigh In On Nanobiotix

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. OLD Mission Capital LLC acquired a new stake in Nanobiotix in the fourth quarter valued at $139,000. Jane Street Group LLC acquired a new stake in Nanobiotix in the 4th quarter valued at about $73,000. Millennium Management LLC bought a new position in Nanobiotix during the fourth quarter worth about $39,000. Finally, Geode Capital Management LLC bought a new position in Nanobiotix during the fourth quarter worth about $29,000. 38.81% of the stock is owned by institutional investors.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.